(Q84831447)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Novel agents in acute myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

main subject

acute myeloid leukemia

1 reference

inferred from title

author name string

Alexander Ungewickell

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Bruno C Medeiros

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

6 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hematology

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

178-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907734%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12185-012-1151-5

11 February 2020

exact match

0 references

cites work

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms

1 reference

12 December 2020

DNMT3A Mutations in Acute Myeloid Leukemia

1 reference

12 December 2020

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma

1 reference

12 December 2020

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia

1 reference

12 December 2020

HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation.

1 reference

12 December 2020

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

12 December 2020

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

1 reference

12 December 2020

Age and acute myeloid leukemia

1 reference

12 December 2020

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

1 reference

12 December 2020

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

1 reference

12 December 2020

Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

1 reference

12 December 2020

Mutation in TET2 in myeloid cancers

1 reference

12 December 2020

HSP90 and the chaperoning of cancer

1 reference

12 December 2020

Acute myeloid leukaemia in the elderly: a review

1 reference

12 December 2020

In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy.

1 reference

12 December 2020

Chromosomal passengers: conducting cell division

1 reference

12 December 2020

Epigenetics in cancer

1 reference

12 December 2020

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

12 December 2020

Recurring mutations found by sequencing an acute myeloid leukemia genome

1 reference

12 December 2020

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.

1 reference

12 December 2020

Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome

1 reference

12 December 2020

Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience

1 reference

12 December 2020

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

12 December 2020

Histone deacetylase inhibitors in cancer therapy

1 reference

12 December 2020

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

1 reference

12 December 2020

Anthracycline dose intensification in acute myeloid leukemia

1 reference

12 December 2020

Resistance, epigenetics and the cancer ecosystem

1 reference

12 December 2020

First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

1 reference

12 December 2020

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia

1 reference

12 December 2020

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

1 reference

12 December 2020

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.

1 reference

12 December 2020

Mechanism of action of lenalidomide in hematological malignancies

1 reference

12 December 2020

Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

1 reference

12 December 2020

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

1 reference

12 December 2020

Personalized oncology through integrative high-throughput sequencing: a pilot study

1 reference

12 December 2020

A pilot pharmacokinetic study of oral azacitidine

1 reference

12 December 2020

Global identification of modular cullin-RING ligase substrates

1 reference

12 December 2020

Modern approaches to treating acute promyelocytic leukemia

1 reference

12 December 2020

Treatment of acute myelogenous leukemia with outpatient azacitidine

1 reference

12 December 2020

Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital

1 reference

12 December 2020

AZD1152 rapidly and negatively affects the growth and survival of human acute myeloid leukemia cells in vitro and in vivo

1 reference

12 December 2020